Global Pantoprazole Injection Market Size, Share, and Trends Analysis Report, By Application (Hospital, Special Clinic, and Recovery Center) Forecast Period (2022-2028)

The global pantoprazole injection market is anticipated to grow at a significant CAGR 6% during the forecast period (2022-2028). Pantoprazole injection is used to treat gastroesophageal reflux disease (GERD; a condition in which backward flow of acid from the stomach causes heartburn and may cause injury to the esophagus [the tube that connects the throat and stomach]) in people who have had esophageal damage and are unable to take pantoprazole by mouth. It is also used to treat Zollinger-Ellison syndrome, a disorder in which the stomach generates too much acid (tumors in the pancreas and small intestine that caused increased production of stomach acid). GERD and ulcers are aided in the expansion of the rabeprazole sodium market.

In October 2018, According to the National Library of Medicine, GERD affects 18.1–27.8% of people in North America, 8.8–25.9% of people in Europe, 2.5–7.8% of people in East Asia, 8.7–33.1% of people in the Middle East, 11.6% of people in Australia, and 23.0% of people in South America. Thus, its rising prevalence will boost the demand for pantoprazole injection during the forecast period.

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, in order to stay competitive in the market. For instance-

• In November 2020, Sandoz Inc. announced an agreement ot supply pantoprazole sodium for injection, 40 mg to Civica Rx, to help decrease supply shortages, with many other medicines on the way. Pantoprazole is the first Sandoz drug to be delivered to Civica since the deal was signed in July. It is a proton pump inhibitor used to treat GERD in individuals with a history of erosive esophagitis for a short period of time (7 to 10 days).
• In October 2019, the pantoprazole injectable is available from Sun Pharmaceuticals. The drug is used to treat GERD and pathological hypersecretion, such as Zollinger-Ellison Syndrome.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- AuroMedics Pharma LLC, Taj Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals plc, and Wellona Pharma, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Pantoprazole Injection Market Report by Segment

By Application

• Hospital
• Special Clinic
• Recovery Center